CN107296863A - A kind of medicine for treating senile dementia - Google Patents

A kind of medicine for treating senile dementia Download PDF

Info

Publication number
CN107296863A
CN107296863A CN201710452423.0A CN201710452423A CN107296863A CN 107296863 A CN107296863 A CN 107296863A CN 201710452423 A CN201710452423 A CN 201710452423A CN 107296863 A CN107296863 A CN 107296863A
Authority
CN
China
Prior art keywords
parts
senile dementia
rhodiola root
medicine
kaempferol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710452423.0A
Other languages
Chinese (zh)
Inventor
秦杰军
秦川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEFEI CHUANDI MEDICAL TECHNOLOGY Co Ltd
Original Assignee
HEFEI CHUANDI MEDICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEFEI CHUANDI MEDICAL TECHNOLOGY Co Ltd filed Critical HEFEI CHUANDI MEDICAL TECHNOLOGY Co Ltd
Priority to CN201710452423.0A priority Critical patent/CN107296863A/en
Publication of CN107296863A publication Critical patent/CN107296863A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/29Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/41Crassulaceae (Stonecrop family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533Leonurus (motherwort)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of medicine for treating senile dementia, according to the mass fraction, including 10~14 parts of 120~180 parts of Kaempferol, 250~400 parts of rhodiola root, 160~200 parts of grass-leaved sweetflag, 120~160 parts of climbing seedbox herb, 80~120 parts of rhodiola root, 30~60 parts of earthworm charcoal, 8~20 parts of acetyl-L-carnitine, 800~1200 parts of Radix Caulophylli and motherwort.Present invention applicant obtains the pharmaceutical formulation of scientific and reasonable treatment senile dementia, the invention belongs to treat senile dementia using Kaempferol first by lot of experiments;After the various drug regimens of the present invention, its drug effect cooperates, and can treat senile dementia caused by a variety of causes, effect is good, instant effect.

Description

A kind of medicine for treating senile dementia
Technical field
The present invention relates to a kind of medicine for treating senile dementia.
Background technology
Alzheimer disease (Alzheimer's disease, abbreviation AD), is a kind of nervus retrogression disease generally occurred Disease.It is AD to have up to 50%-60% in dementia patients, and its main clinic symptoms shows as the cognitive decrease of progressive.Greatly Quantity research confirms that the phenomenon that amyloid-beta (A β) abnormal accumulation is had in the brain of AD patient occurs, wherein A β 25-35 couple Nerve cell has direct toxic action, is the major toxicity fragment of amyloid-beta, and being with its preparation AD external model can Capable.
At present, ratify mainly have (1) anticholinesterase for the medicine of senile dementia disease treatment both at home and abroad, commonly use Medicine has donepezil, galanthamine etc..(2) glutamate receptor antagonists, common drug has memantine.But said medicine Treat senile dementia and act on single, therapeutic effect is limited, with certain side effect.Therefore, research and development preventing and treating is old The health food of dull-witted natural safety turns into current important research topic.
Kaempferol (Kaempferol) belong to flavone compound, be a kind of phytoestrogen composition, be widely distributed in shaddock, In the green plantss such as witch's fibert, tealeaves, the Chinese medicine such as various water fruits and vegetables and the rhizome of davallia.Numerous studies confirm that Kaempferol has Wider biological activity, it can pre- anti-cancer, antagonism inflammation and microorganism, and cardiovascular and neuron can be produced certain Protective effect.
The content of the invention
The technical problem to be solved in the present invention is to provide a kind of medicine for treating senile dementia.
A kind of medicine for treating senile dementia, its according to the mass fraction, its composition of raw materials is as follows:
120~180 parts of Kaempferol, 250~400 parts of rhodiola root, 160~200 parts of grass-leaved sweetflag, 120~160 parts of climbing seedbox herb, 80~120 parts of rhodiola root, 30~60 parts of earthworm charcoal, 8~20 parts of acetyl-L-carnitine, 800~1200 parts of Radix Caulophylli, motherwort 10 ~14 parts;
Wherein, described Radix Caulophylli includes according to the mass fraction:4~6 parts of polyvinyl alcohol, 1~3 part of gelatinized starch, phosphorus stone 2~3 parts of cream, 1~2 part of ammonium sulfate, 1~2 part of sodium chloride, 0.7~0.9 part of prodan, 2~4 parts of potassium chloride, high hydroscopic resin 0.4~0.6 part.
Further, according to the mass fraction, its composition of raw materials is as follows:
140~160 parts of Kaempferol, 300~400 parts of rhodiola root, 160~180 parts of grass-leaved sweetflag, 120~150 parts of climbing seedbox herb, 85~95 parts of rhodiola root, 30~45 parts of earthworm charcoal, 10~20 parts of acetyl-L-carnitine, 850~950 parts of water, motherwort 10~13 Part.
Further, according to the mass fraction, its composition of raw materials is as follows:
150 parts of Kaempferol, 320 parts of rhodiola root, 180 parts of grass-leaved sweetflag, 140 parts of climbing seedbox herb, 90 parts of rhodiola root, earthworm charcoal 40 Part, 14 parts of acetyl-L-carnitine, 900 parts of water, 13 parts of motherwort.
Further, according to the mass fraction, its composition of raw materials is as follows:
120 parts of Kaempferol, 400 parts of rhodiola root, 160 parts of grass-leaved sweetflag, 160 parts of climbing seedbox herb, 80 parts of rhodiola root, earthworm charcoal 60 Part, 8 parts of acetyl-L-carnitine, 1200 parts of Radix Caulophylli, 10 parts of motherwort.
Further, according to the mass fraction, its composition of raw materials is as follows:
180 parts of Kaempferol, 250 parts of rhodiola root, 200 parts of grass-leaved sweetflag, 120 parts of climbing seedbox herb, 120 parts of rhodiola root, earthworm charcoal 30 Part, 20 parts of acetyl-L-carnitine, 800 parts of Radix Caulophylli, 14 parts of motherwort.
The beneficial effect that the present invention is reached:
Present invention applicant obtains the pharmaceutical formulation of scientific and reasonable treatment senile dementia by lot of experiments.This Invention belongs to treats senile dementia using Kaempferol first, and Kaempferol alternative acts on ER β, promotes p-ERK1/2 table Reach, active cell ER/MAPK signal transduction pathways, and the expression of Bcl-2 albumen is promoted by the approach, suppress Caspase-3 With the expression of Bax albumen, PC-12 cells are prevented to start apoptosis program, so as to be produced to the PC-12 cells damaged by A β 25-35 Protective effect;After the various drug regimens of the present invention, its drug effect cooperates, and can treat senile dementia caused by a variety of causes Disease, effect is good, instant effect.
Embodiment
The preferred embodiments of the present invention are illustrated below, it will be appreciated that preferred embodiment described herein is only used In the description and interpretation present invention, it is not intended to limit the present invention.
Embodiment 1
A kind of medicine for treating senile dementia, according to the mass fraction, its composition of raw materials is as follows:
120 parts of Kaempferol, 400 parts of rhodiola root, 160 parts of grass-leaved sweetflag, 120 parts of climbing seedbox herb, 80 parts of rhodiola root, earthworm charcoal 60 Part, 20 parts of acetyl-L-carnitine, 1200 parts of Radix Caulophylli, 14 parts of motherwort.
Embodiment 2
A kind of medicine for treating senile dementia, according to the mass fraction, its composition of raw materials is as follows:
180 parts of Kaempferol, 250 parts of rhodiola root, 200 parts of grass-leaved sweetflag, 160 parts of climbing seedbox herb, 120 parts of rhodiola root, earthworm charcoal 30 Part, 8 parts of acetyl-L-carnitine, 800 parts of Radix Caulophylli, 10 parts of motherwort.
Embodiment 3
A kind of medicine for treating senile dementia, according to the mass fraction, its composition of raw materials is as follows:
140 parts of Kaempferol, 300 parts of rhodiola root, 160 parts of grass-leaved sweetflag, 120 parts of climbing seedbox herb, 85 parts of rhodiola root, earthworm charcoal 30 Part, 10 parts of acetyl-L-carnitine, 850 parts of Radix Caulophylli, 10 parts of motherwort.
Embodiment 4
A kind of medicine for treating senile dementia, according to the mass fraction, its composition of raw materials is as follows:
160 parts of Kaempferol, 400 parts of rhodiola root, 180 parts of grass-leaved sweetflag, 150 parts of climbing seedbox herb, 95 parts of rhodiola root, earthworm charcoal 45 Part, 20 parts of acetyl-L-carnitine, 950 parts of Radix Caulophylli, 13 parts of motherwort.
Embodiment 5
A kind of medicine for treating senile dementia, according to the mass fraction, its composition of raw materials is as follows:
150 parts of Kaempferol, 320 parts of rhodiola root, 180 parts of grass-leaved sweetflag, 140 parts of climbing seedbox herb, 90 parts of rhodiola root, earthworm charcoal 40 Part, 14 parts of acetyl-L-carnitine, 900 parts of Radix Caulophylli, 13 parts of motherwort.
It is decocted in water for oral dose, every three days one, twice daily.
Model case
Mr. Wang, male, 74 years old, on March 14th, 2013, head was examined, and dizzy palpitaition, insomnia and dreamful sleep, the soreness of waist, mind is blunt, and intelligence is sharp Subtract, it is forgetful.It is repeatedly lost, the medicine of the present invention is taken, respectively takes 1 time, continuously takes three months sooner or later daily, after three months, patient Various ill symptomses disappear, intelligence recovers normal, and sleep quality is improved, spirit and QI cleaning.
Lee, female, 77 years old, on June 12nd, 2014, head was examined.Nearest half a year emotional lability, haves the fidgets, and irritability is usually muttered Mutter and speak to oneself, burnout is thought to crouch, and receives less weak.The medicine of the present invention is taken, respectively takes 1 time, continuously takes 3 months sooner or later daily, patient's Various ill symptomses disappear, and memory is recovered, and when anything crops up unruffled, it is even-tempered and good-humoured to speak, and appetite recovers normal.
Zheng, female, 82 years old, on March 11st, 2013, head was examined.Usually mumble, burnout is thought sleeping, receives less weak, go out fan Road.The medicine of the present invention is taken, respectively takes 1 time, continuously takes 2.5 months sooner or later daily, the various ill symptomses of patient disappear, mood Stable, memory is recovered, and appetite recovers normal.
Finally it should be noted that:The preferred embodiments of the present invention are the foregoing is only, are not intended to limit the invention, Although the present invention is described in detail with reference to the foregoing embodiments, for those skilled in the art, it still may be used To be modified to the technical scheme described in foregoing embodiments, or equivalent substitution is carried out to which part technical characteristic. Within the spirit and principles of the invention, any modification, equivalent substitution and improvements made etc., should be included in the present invention's Within protection domain.

Claims (5)

1. a kind of medicine for treating senile dementia, it is characterised in that according to the mass fraction, its composition of raw materials is as follows:
120~180 parts of Kaempferol, 250~400 parts of rhodiola root, 160~200 parts of grass-leaved sweetflag, 120~160 parts of climbing seedbox herb, red scape It 80~120 parts, 30~60 parts of earthworm charcoal, 8~20 parts of acetyl-L-carnitine, 800~1200 parts of Radix Caulophylli and motherwort 10~ 14 parts.
2. the medicine of senile dementia is treated as claimed in claim 1, it is characterised in that according to the mass fraction, its composition of raw materials It is as follows:
140~160 parts of Kaempferol, 300~400 parts of rhodiola root, 160~180 parts of grass-leaved sweetflag, 120~150 parts of climbing seedbox herb, red scape 10~13 parts of it 85~95 parts, 30~45 parts of earthworm charcoal, 10~20 parts of acetyl-L-carnitine, 850~950 parts of water and motherwort.
3. the medicine of senile dementia is treated as claimed in claim 2, it is characterised in that according to the mass fraction, its composition of raw materials It is as follows:
150 parts of Kaempferol, 320 parts of rhodiola root, 180 parts of grass-leaved sweetflag, 140 parts of climbing seedbox herb, 90 parts of rhodiola root, 40 parts of earthworm charcoal, second 13 parts of 14 parts of acyl l-cn, 900 parts of water and motherwort.
4. the medicine of senile dementia is treated as claimed in claim 1, it is characterised in that according to the mass fraction, its composition of raw materials It is as follows:
120 parts of Kaempferol, 400 parts of rhodiola root, 160 parts of grass-leaved sweetflag, 160 parts of climbing seedbox herb, 80 parts of rhodiola root, 60 parts of earthworm charcoal, second 10 parts of 8 parts of acyl l-cn, 1200 parts of Radix Caulophylli and motherwort.
5. the medicine of senile dementia is treated as claimed in claim 1, it is characterised in that according to the mass fraction, its composition of raw materials It is as follows:
180 parts of Kaempferol, 250 parts of rhodiola root, 200 parts of grass-leaved sweetflag, 120 parts of climbing seedbox herb, 120 parts of rhodiola root, 30 parts of earthworm charcoal, second 14 parts of 20 parts of acyl l-cn, 800 parts of Radix Caulophylli and motherwort.
CN201710452423.0A 2017-06-15 2017-06-15 A kind of medicine for treating senile dementia Pending CN107296863A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710452423.0A CN107296863A (en) 2017-06-15 2017-06-15 A kind of medicine for treating senile dementia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710452423.0A CN107296863A (en) 2017-06-15 2017-06-15 A kind of medicine for treating senile dementia

Publications (1)

Publication Number Publication Date
CN107296863A true CN107296863A (en) 2017-10-27

Family

ID=60135706

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710452423.0A Pending CN107296863A (en) 2017-06-15 2017-06-15 A kind of medicine for treating senile dementia

Country Status (1)

Country Link
CN (1) CN107296863A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108671019A (en) * 2018-06-14 2018-10-19 深圳怡康妇产医院 Pregnancy promoting soup
CN109925463A (en) * 2017-12-18 2019-06-25 南宁多灵生物科技有限公司 A kind of pharmaceutical composition of brain tonic and intelligence development
CN109939100A (en) * 2019-04-22 2019-06-28 井冈山大学 Utilize the acetylcholine enzyme inhibitor of close plumage rhizome of cyrtomium preparation, preparation method and application
CN112586659A (en) * 2020-12-11 2021-04-02 海南黄嘉堡生物科技有限公司 Formula for treating senile dementia and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940834A (en) * 2012-10-10 2013-02-27 肥西县中医院 Traditional Chinese medicine for treating senile dementia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940834A (en) * 2012-10-10 2013-02-27 肥西县中医院 Traditional Chinese medicine for treating senile dementia

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109925463A (en) * 2017-12-18 2019-06-25 南宁多灵生物科技有限公司 A kind of pharmaceutical composition of brain tonic and intelligence development
CN108671019A (en) * 2018-06-14 2018-10-19 深圳怡康妇产医院 Pregnancy promoting soup
CN109939100A (en) * 2019-04-22 2019-06-28 井冈山大学 Utilize the acetylcholine enzyme inhibitor of close plumage rhizome of cyrtomium preparation, preparation method and application
CN109939100B (en) * 2019-04-22 2022-04-19 井冈山大学 Acetylcholine enzyme inhibitor prepared from Cyrtomium fortunei, preparation method and application
CN112586659A (en) * 2020-12-11 2021-04-02 海南黄嘉堡生物科技有限公司 Formula for treating senile dementia and preparation method thereof

Similar Documents

Publication Publication Date Title
CN107296863A (en) A kind of medicine for treating senile dementia
CN104367765A (en) Traditional Chinese medicinal composition for treating depression as well as preparation method and application thereof
CN102430056A (en) Medicament for treating hypertension
CN103719491B (en) A kind of sealwort invigorating the spleen moistening lung health protection tea and preparation method thereof
CN102579857B (en) Medicament formula for treating depressive psychosis and madness (schizophrenia) and preparation method thereof
CN104248722A (en) Medicament for treating female hypersexuality
CN106924628A (en) For Chinese medicine composition for improving the health care of sleep and preparation method thereof
CN105726576A (en) Tablet used for treating angina in slow-release stage and preparation method thereof
CN109833381A (en) A kind of pure plant drug composition improving sleep
CN102908396B (en) Chinese medicinal composition for promoting sleeping and preparation method thereof
CN104162005A (en) Traditional Chinese medicine for treating epilepsy
CN103330912B (en) Traditional Chinese medicament for treating insomnia
CN103798472B (en) A kind of health protection tea and health care's preparation
CN104784495A (en) Traditional Chinese medicine preparation for treating infantile convulsion and preparation method
CN1954841B (en) Medicine for treating chronic pharyngitis
CN102552423B (en) Medicinal composition for treating migraine
CN104095917A (en) Chinese patent medicine for treating child hyperpyretic convulsion and preparation method thereof
CN102885539B (en) Drug pillow capable of relieving night terrors of children
CN105535595A (en) Traditional Chinese medicine composition for calming nerves, tranquilizing, clearing dryness-heat and alleviating mental illness and preparation method thereof
CN105561007A (en) Traditional Chinese medicine preparation for treating infantile influenza and preparation method
CN105147828A (en) Traditional Chinese medicine for treating sleep apnea syndrome and preparation method thereof
CN106109301A (en) A kind of Chinese herbal medicine hair washing water treating insomnia and preparation method thereof
CN104784353A (en) Traditional Chinese medicine for treating senile dementia
CN103520414B (en) Chinese medicament for treating bronchial asthma
CN104524266A (en) Preparation method of ion introduction agent for treating children hyperthyroidism

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20171027

RJ01 Rejection of invention patent application after publication